N-Formylsarcolysine
N-Formylsarcolysine has antitumor activity, and inhibits leukemia by increasing the Hb and erythrocyte levels and decreasing the number of leukocytes. N-Formylsarcolysine also involves in glioblastoma and other diseases research[1][2].
Product Specifications
CAS Number
26367-45-3
UNSPSC
12352005
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/n-formylsarcolysine.html
Solubility
10 mM in DMSO
Smiles
O=CNC(CC1=CC=C(N(CCCl)CCCl)C=C1)C(O)=O
Molecular Formula
C14H18Cl2N2O3
Molecular Weight
333.21
References & Citations
[1]HAN J, et al. [STUDIES ON ANTITUMOR DRUGS. VII. STUDIES ON THE ANTITUMOR SPECTRUM AND TOXICITY OF N-FORMYLSARCOLYSINE]. Yao Xue Xue Bao. 1964 May;11:330-7. Chinese. |[2]ChenYY, et al. Quinoline derivative for treating glioblastoma: China, CN112294814[P]. 2021-02-02.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-UNEL-M0004-01 5x 96 Tests
Uncoated Mouse ADP/Acrp30 (Adiponectin) ELISA Kit
Sign In for Pricing
View Details E-UNEL-M0004-02 15x 96 Tests
Uncoated Mouse ADP/Acrp30 (Adiponectin) ELISA Kit
Sign In for Pricing
View Details 
